1 |
Bell, D. A. (2005) Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18 (Suppl 2), S19-32.
DOI
ScienceOn
|
2 |
Gilks, C. B. (2010) Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma. J. Oncol. 2010, 740968.
|
3 |
Shih Ie, M. and Kurman, R. J. (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164, 1511-1518.
DOI
ScienceOn
|
4 |
Auersperg, N., Ota, T. and Mitchell, G. W. (2002) Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int. J. Gynecol. Cancer 12, 691-703.
DOI
ScienceOn
|
5 |
Scully, R. E. (1995) Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int. J. Gynaecol. Obstet. 49 (Suppl), S9-15.
DOI
ScienceOn
|
6 |
Lee, Y., Miron, A., Drapkin, R., Nucci, M. R., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R. W., Cramer, D. W., McKeon, F. D. and Crum, C. P. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26-35.
DOI
ScienceOn
|
7 |
Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K. and Leung, P. C. (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255-288.
DOI
ScienceOn
|
8 |
Burdette, J. E., Kurley, S. J., Kilen, S. M., Mayo, K. E. and Woodruff, T. K. (2006) Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice. Endocrinology 147, 2338-2345.
DOI
ScienceOn
|
9 |
Auersperg, N., Woo, M. M. and Gilks, C. B. (2008) The origin of ovarian carcinomas: a developmental view. Gynecol. Oncol. 110, 452-454.
DOI
ScienceOn
|
10 |
Fathalla, M. F. (1971) Incessant ovulation--a factor in ovarian neoplasia? Lancet 2, 163.
|
11 |
Garson, K., Shaw, T. J., Clark, K. V., Yao, D. S. and Vanderhyden, B. C. (2005) Models of ovarian cancer--are we there yet? Mol. Cell Endocrinol. 239, 15-26.
DOI
ScienceOn
|
12 |
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M. J. (2009) Cancer statistics, 2009. CA Cancer. J. Clin. 59, 225-249.
DOI
ScienceOn
|
13 |
Auersperg, N., Maines-Bandiera, S. L. and Dyck, H. G. (1997) Ovarian carcinogenesis and the biology of ovarian surface epithelium. J. Cell. Physiol. 173, 261-265.
DOI
ScienceOn
|
14 |
Liang, S., Yang, N., Pan, Y., Deng, S., Lin, X., Yang, X., Katsaros, D., Roby, K. F., Hamilton, T. C., Connolly, D. C., Coukos, G. and Zhang, L. (2009) Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation. PLoS One 4, e4295.
DOI
ScienceOn
|
15 |
Zheng, W., Magid, M. S., Kramer, E. E. and Chen, Y. T. (1996) Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am. J. Pathol. 148, 47-53.
|
16 |
Mishina, Y., Whitworth, D. J., Racine, C. and Behringer, R. R. (1999) High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140, 2084-2088.
DOI
ScienceOn
|
17 |
Bristol-Gould, S. K., Hutten, C. G., Sturgis, C., Kilen, S. M., Mayo, K. E. and Woodruff, T. K. (2005) The development of a mouse model of ovarian endosalpingiosis. Endocrinology 146, 5228-5236.
DOI
ScienceOn
|
18 |
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D. and Jacks, T. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med. 11, 63-70.
DOI
ScienceOn
|
19 |
Mullany, L. K., Fan, H. Y., Liu, Z., White, L. D., Marshall, A., Gunaratne, P., Anderson, M. L., Creighton, C. J., Xin, L., Deavers, M., Wong, K. K. and Richards, J. S. (2011) Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene.
|
20 |
Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B. and Gray, J. W. (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21, 99-102.
DOI
ScienceOn
|
21 |
Laviolette, L. A., Garson, K., Macdonald, E. A., Senterman, M. K., Courville, K., Crane, C. A. and Vanderhyden, B. C. (2010) 17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 151, 929-938.
DOI
ScienceOn
|
22 |
Tanyi, J. L., Lapushin, R., Eder, A., Auersperg, N., Tabassam, F. H., Roth, J. A., Gu, J., Fang, B., Mills, G. B. and Wolf, J. (2002) Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells. Gynecol. Oncol. 85, 451-458.
DOI
ScienceOn
|
23 |
Zhang, Y., Huang, G., Shornick, L. P., Roswit, W. T., Shipley, J. M., Brody, S. L. and Holtzman, M. J. (2007) A transgenic FOXJ1-Cre system for gene inactivation in ciliated epithelial cells. Am. J. Respir. Cell Mol. Biol. 36, 515-519.
DOI
ScienceOn
|
24 |
Karst, A. M., Levanon, K. and Drapkin, R. (2011) Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc. Natl. Acad. Sci. U.S.A. 108, 7547- 7552.
DOI
ScienceOn
|
25 |
Miyoshi, I., Takahashi, K., Kon, Y., Okamura, T., Mototani, Y., Araki, Y. and Kasai, N. (2002) Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven Simian Virus 40 large T-antigen: tumor formation and its hormonal regulation. Mol. Reprod. Dev. 63, 168-176.
DOI
ScienceOn
|
26 |
Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Hua, X., Harris, S. S., Vanderhyden, B. C. and Hamilton, T. C. (2003) Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 63, 1389-1397.
|
27 |
Quinn, B. A., Xiao, F., Bickel, L., Martin, L., Hua, X., Klein-Szanto, A. and Connolly, D. C. (2010) Development of a syngeneic mouse model of epithelial ovarian cancer. J. Ovarian Res. 3, 24.
DOI
ScienceOn
|
28 |
Chodankar, R., Kwang, S., Sangiorgi, F., Hong, H., Yen, H. Y., Deng, C., Pike, M. C., Shuler, C. F., Maxson, R. and Dubeau, L. (2005) Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr. Biol. 15, 561-565.
DOI
ScienceOn
|
29 |
Jarboe, E. A., Pizer, E. S., Miron, A., Monte, N., Mutter, G. L. and Crum, C. P. (2009) Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod. Pathol. 22, 345-350.
DOI
ScienceOn
|
30 |
Corney, D. C., Flesken-Nikitin, A., Choi, J. and Nikitin, A. Y. (2008) Role of p53 and Rb in ovarian cancer. Adv. Exp. Med. Biol. 622, 99-117.
DOI
|
31 |
Gowen, L. C., Johnson, B. L., Latour, A. M., Sulik, K. K. and Koller, B. H. (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12, 191-194.
DOI
ScienceOn
|
32 |
Clark-Knowles, K. V., Garson, K., Jonkers, J. and Vanderhyden, B. C. (2007) Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Exp. Cell Res. 313, 133-145.
DOI
ScienceOn
|
33 |
Boyd, J. (2005) Mouse models of gynecologic pathology. N. Engl. J. Med. 352, 2240-2242.
DOI
ScienceOn
|
34 |
Buller, R. E., Lallas, T. A., Shahin, M. S., Sood, A. K., Hatterman-Zogg, M., Anderson, B., Sorosky, J. I. and Kirby, P. A. (2001) The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer. Clin Cancer Res. 7, 831-838.
|
35 |
Clark-Knowles, K. V., Senterman, M. K., Collins, O. and Vanderhyden, B. C. (2009) Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas. PLoS One 4, e8534.
DOI
ScienceOn
|
36 |
Quinn, B. A., Brake, T., Hua, X., Baxter-Jones, K., Litwin, S., Ellenson, L. H. and Connolly, D. C. (2009) Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. PLoS One 4, e8404.
DOI
ScienceOn
|
37 |
Flesken-Nikitin, A., Choi, K. C., Eng, J. P., Shmidt, E. N. and Nikitin, A. Y. (2003) Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63, 3459-3463.
|
38 |
Maronpot, R. R. (1987) Ovarian toxicity and carcinogenicity in eight recent National Toxicology Program studies. Environ. Health Perspect 73, 125-130.
DOI
|
39 |
Bai, W., Oliveros-Saunders, B., Wang, Q., Acevedo- Duncan, M. E. and Nicosia, S. V. (2000) Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev. Biol. Anim. 36, 657-666.
DOI
ScienceOn
|
40 |
Umezu, T., Hanazono, M., Aizawa, S. and Tomooka, Y. (2003) Characterization of newly established clonal oviductal cell lines and differential hormonal regulation of gene expression. In Vitro Cell Dev. Biol. Anim. 39, 146-156.
|
41 |
Crist, K. A., Zhang, Z., You, M., Gunning, W. T., Conran, P. B., Steele, V. E. and Lubet, R. A. (2005) Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 26, 951-957.
DOI
|
42 |
Ziecik, A. J., Kaczmarek, M. M., Blitek, A., Kowalczyk, A. E., Li, X. and Rahman, N. A. (2007) Novel biological and possible applicable roles of LH/hCG receptor. Mol. Cell. Endocrinol. 269, 51-60.
DOI
ScienceOn
|
43 |
Tunca, J. C., Erturk, E. and Bryan, G. T. (1985) Chemical induction of ovarian tumors in rats. Gynecol. Oncol. 21, 54-64.
DOI
ScienceOn
|
44 |
Stewart, S. L., Querec, T. D., Ochman, A. R., Gruver, B. N., Bao, R., Babb, J. S., Wong, T. S., Koutroukides, T., Pinnola, A. D., Klein-Szanto, A., Hamilton, T. C. and Patriotis, C. (2004) Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res. 64, 8177-8183.
DOI
ScienceOn
|
45 |
Wang, Y., Zhang, Z., Lu, Y., Yao, R., Jia, D., Wen, W., LaRegina, M., Crist, K., Lubet, R. and You, M. (2008) Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation. Mol. Cancer Res. 6, 99-109.
DOI
ScienceOn
|
46 |
Nofech-Mozes, S., Khalifa, M. A., Ismiil, N., Saad, R. S., Hanna, W. M., Covens, A. and Ghorab, Z. (2008) Immunophenotyping of serous carcinoma of the female genital tract. Mod. Pathol. 21, 1147-1155.
DOI
ScienceOn
|
47 |
Nowee, M. E., Dorsman, J. C., Piek, J. M., Kosma, V. M., Hamalainen, K., Verheijen, R. H. and van Diest, P. J. (2007) HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study. Histopathology 51, 666-673.
DOI
ScienceOn
|
48 |
Trevino, L. S., Giles, J. R., Wang, W., Urick, M. E. and Johnson, P. A. (2010) Gene Expression Profiling Reveals Differentially Expressed Genes in Ovarian Cancer of the Hen: Support for Oviductal Origin? Hormones and Cancer 1, 177-186.
DOI
|
49 |
Gregson, R. L., Lewis, D. J. and Abbott, D. P. (1984) Spontaneous ovarian neoplasms of the laboratory rat. Vet. Pathol. 21, 292-299.
DOI
|
50 |
Greenacre, C. B. (2004) Spontaneous tumors of small mammals. Vet. Clin. North. Am. Exot. Anim. Pract. 7, 627- 651, vi.
DOI
ScienceOn
|
51 |
Sharrow, A. C., Ronnett, B. M., Thoburn, C. J., Barber, J. P., Giuntoli, R. L., 2nd, Armstrong, D. K., Jones, R. J. and Hess, A. D. (2010) Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats. J. Ovarian Res. 3, 9.
DOI
ScienceOn
|
52 |
Komatsu, M. and Fujita, H. (1978) Electron-microscopic studies on the development and aging of the oviduct epithelium of mice. Anat. Embryol. (Berl) 152, 243-259.
DOI
|
53 |
Critoph, F. N. and Dennis, K. J. (1977) The cellular composition of the human oviduct epithelium. Br. J. Obstet. Gynaecol. 84, 219-221.
DOI
|
54 |
Baird, D. T., Baker, T. G., McNatty, K. P. and Neal, P. (1975) Relationship between the secretion of the corpus luteum and the length of the follicular phase of the ovarian cycle. J. Reprod. Fertil. 45, 611-619.
DOI
ScienceOn
|
55 |
Cline, J. M., Wood, C. E., Vidal, J. D., Tarara, R. P., Buse, E., Weinbauer, G. F., de Rijk, E. P. and van Esch, E. (2008) Selected background findings and interpretation of common lesions in the female reproductive system in macaques. Toxicol. Pathol. 36, 142s-163s.
DOI
ScienceOn
|
56 |
Rodriguez, G. C., Nagarsheth, N. P., Lee, K. L., Bentley, R. C., Walmer, D. K., Cline, M., Whitaker, R. S., Isner, P., Berchuck, A., Dodge, R. K. and Hughes, C. L. (2002) Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta. J. Natl. Cancer Inst. 94, 50-60.
DOI
ScienceOn
|
57 |
Fredrickson, T. N. (1987) Ovarian tumors of the hen. Environ. Health Perspect 73, 35-51.
DOI
|
58 |
Rodriguez, G. C., Walmer, D. K., Cline, M., Krigman, H., Lessey, B. A., Whitaker, R. S., Dodge, R. and Hughes, C. L. (1998) Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J. Soc. Gynecol. Investig. 5, 271-276.
DOI
ScienceOn
|
59 |
Lu, K. H., Yates, M. S. and Mok, S. C. (2009) The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention. Cancer Prev. Res. (Phila Pa) 2, 773-775.
DOI
ScienceOn
|
60 |
Barnes, M. N., Berry, W. D., Straughn, J. M., Kirby, T. O., Leath, C. A., Huh, W. K., Grizzle, W. E. and Partridge, E. E. (2002) A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol. Oncol. 87, 57-63.
DOI
ScienceOn
|
61 |
Barua, A., Bitterman, P., Abramowicz, J. S., Dirks, A. L., Bahr, J. M., Hales, D. B., Bradaric, M. J., Edassery, S. L., Rotmensch, J. and Luborsky, J. L. (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int. J. Gynecol. Cancer 19, 531-539.
DOI
ScienceOn
|
62 |
Hakim, A. A., Barry, C. P., Barnes, H. J., Anderson, K. E., Petitte, J., Whitaker, R., Lancaster, J. M., Wenham, R. M., Carver, D. K., Turbov, J., Berchuck, A., Kopelovich, L. and Rodriguez, G. C. (2009) Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev. Res. (Phila) 2, 114-121.
DOI
ScienceOn
|
63 |
Press, J. Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S. E., Blood, K. A., Smith, M., Spellman, P. T., Wang, Y., Miller, D. M., Horsman, D., Faham, M., Gilks, C. B., Gray, J. and Huntsman, D. G. (2008) Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer 8, 17.
DOI
ScienceOn
|
64 |
Alexander, B. M., Van Kirk, E. A., Naughton, L. M. and Murdoch, W. J. (2007) Ovarian morphometrics in TP53-deficient mice. Anat. Rec. (Hoboken) 290, 59-64.
DOI
ScienceOn
|
65 |
Press, J. Z., Wurz, K., Norquist, B. M., Lee, M. K., Pennil, C., Garcia, R., Welcsh, P., Goff, B. A. and Swisher, E. M. (2010) Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers. Neoplasia 12, 993-1002.
DOI
|
66 |
Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A. E. and Karlan, B. Y. (2005) BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet. Gynecol. 106, 1327-1334.
DOI
ScienceOn
|
67 |
Xian, W., Miron, A., Roh, M., Semmel, D. R., Yassin, Y., Garber, J., Oliva, E., Goodman, A., Mehra, K., Berkowitz, R. S., Crum, C. P. and Quade, B. J. (2010) The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J. Pathol. 220, 17-23.
DOI
ScienceOn
|
68 |
Cooper, T. K. and Gabrielson, K. L. (2007) Spontaneous lesions in the reproductive tract and mammary gland of female non-human primates. Birth Defects Res. B. Dev. Reprod. Toxicol. 80, 149-170.
DOI
ScienceOn
|
69 |
Marr-Belvin, A. K., Bailey, C. C., Knight, H. L., Klumpp, S. A., Westmoreland, S. V. and Miller, A. D. (2010) Ovarian pathology in rhesus macaques: a 12-year retrospective. J. Med. Primatol. 39, 170-176.
DOI
ScienceOn
|
70 |
Moore, C. M., Hubbard, G. B., Leland, M. M., Dunn, B. G. and Best, R. G. (2003) Spontaneous ovarian tumors in twelve baboons: a review of ovarian neoplasms in non-human primates. J. Med. Primatol. 32, 48-56.
DOI
ScienceOn
|
71 |
Swisher, E. (2003) Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2. Curr. Womens Health Rep. 3, 27-32.
|
72 |
Ghahremani, M., Foghi, A. and Dorrington, J. H. (1999) Etiology of ovarian cancer: a proposed mechanism. Med. Hypotheses 52, 23-26.
DOI
ScienceOn
|
73 |
Sundfeldt, K., Piontkewitz, Y., Ivarsson, K., Nilsson, O., Hellberg, P., Brannstrom, M., Janson, P. O., Enerback, S. and Hedin, L. (1997) E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer 74, 275-280.
DOI
ScienceOn
|
74 |
Roh, M. H., Kindelberger, D. and Crum, C. P. (2009) Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am. J. Surg. Pathol. 33, 376-383.
DOI
ScienceOn
|
75 |
Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y. and Crum, C. P. (2008) Serous carcinogenesis in the fallopian tube: a descriptive classification. Int. J. Gynecol. Pathol. 27, 1-9.
DOI
ScienceOn
|
76 |
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., Berkowitz, R. S., Muto, M. G. and Crum, C. P. (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am. J. Surg. Pathol. 31, 161-169.
DOI
ScienceOn
|
77 |
Levanon, K., Ng, V., Piao, H. Y., Zhang, Y., Chang, M. C., Roh, M. H., Kindelberger, D. W., Hirsch, M. S., Crum, C. P., Marto, J. A. and Drapkin, R. (2010) Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29, 1103-1113.
DOI
ScienceOn
|
78 |
Kurman, R. J. and Shih Ie, M. (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 34, 433-443.
DOI
ScienceOn
|
79 |
Auersperg, N. (2011) The origin of ovarian carcinomas: a unifying hypothesis. Int. J. Gynecol. Pathol. 30, 12-21.
DOI
ScienceOn
|
80 |
Crum, C. P., Drapkin, R., Kindelberger, D., Medeiros, F., Miron, A. and Lee, Y. (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin. Med. Res. 5, 35-44.
DOI
ScienceOn
|
81 |
Edmondson, R. J., Monaghan, J. M. and Davies, B. R. (2006) Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium. Int. J. Gynecol. Cancer 16, 171-177.
DOI
ScienceOn
|
82 |
Wright, J. W., Pejovic, T., Fanton, J. and Stouffer, R. L. (2008) Induction of proliferation in the primate ovarian surface epithelium in vivo. Hum. Reprod. 23, 129-138.
|
83 |
Parrott, J. A., Doraiswamy, V., Kim, G., Mosher, R. and Skinner, M. K. (2001) Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol. Cell Endocrinol. 172, 213-222.
DOI
ScienceOn
|
84 |
Konishi, I., Kuroda, H. and Mandai, M. (1999) Review: gonadotropins and development of ovarian cancer. Oncology 57 (Suppl 2), 45-48.
DOI
ScienceOn
|
85 |
Chakravarti, S., Collins, W. P., Forecast, J. D., Newton, J. R., Oram, D. H. and Studd, J. W. (1976) Hormonal profiles after the menopause. Br. Med. J. 2, 784-787.
DOI
|
86 |
Espey, L. L. (1994) Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol. Reprod. 50, 233-238.
DOI
ScienceOn
|
87 |
Murdoch, W. J. (2008) Ovulatory factor in ovarian carcinogenesis. Adv. Exp. Med. Biol. 622, 119-128.
DOI
|
88 |
Murdoch, W. J., Townsend, R. S. and McDonnel, A. C. (2001) Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol. Reprod. 65, 1417-1424.
DOI
ScienceOn
|
89 |
Burdette, J. E., Oliver, R. M., Ulyanov, V., Kilen, S. M., Mayo, K. E. and Woodruff, T. K. (2007) Ovarian epithelial inclusion cysts in chronically superovulated CD1 and Smad2 dominant-negative mice. Endocrinology 148, 3595-3604.
DOI
ScienceOn
|